Cancer Research UK logo.
SearchDonate
  • Search

A trial of mogamulizumab for peripheral T cell lymphoma

Overview

Cancer types:

High grade lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at drug called mogamulizumab (also known as KW-0761) for that has got worse or come back after other treatment.

Recruitment start: 4 July 2012

Recruitment end: 10 January 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor John Radford

Supported by

Kyowa Hakko Kirin Pharma

Inc

Last reviewed: 29 Jan 2014

CRUK internal database number: 9840

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.